Anca Raicu-Chelariu

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Real-world data on the clinical impact of molecular tumor boards in high- and low-grade serous ovarian cancer.

Real-world data on the clinical impact of molecular tumor boards in high- and low-grade serous ovarian cancer.

Journal: Frontiers in oncology
Published: February 20, 2026

Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer.

Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer.

Journal: iScience
Published: May 19, 2025

Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer Organoids.

Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer Organoids.

Journal: Methods and protocols
Published: October 04, 2024

IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer.

IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer.

Journal: Cancer research communications
Published: April 10, 2024

Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.

Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.

Journal: International journal of molecular sciences
Published: January 14, 2024

Endothelial p130cas confers resistance to anti-angiogenesis therapy.

Endothelial p130cas confers resistance to anti-angiogenesis therapy.

Journal: Cell reports
Published: June 05, 2023

Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies.

Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies.

Journal: Frontiers in oncology
Published: May 05, 2023

Integrating antibody drug conjugates in the management of gynecologic cancers.

Integrating antibody drug conjugates in the management of gynecologic cancers.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 06, 2023

Immunotherapy in endometrial cancer.

Immunotherapy in endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 06, 2023

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

Journal: Journal of cancer research and clinical oncology
Published: February 09, 2023

PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy.

PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 27, 2023

Updates of placental macrophages: Origins, molecular markers, functions, and related diseases.

Updates of placental macrophages: Origins, molecular markers, functions, and related diseases.

Journal: Journal of reproductive immunology
Published: January 26, 2023
Showing 1-12 of 48

Last Updated: 09/26/2026